Media Advisory - BMO Capital Markets to Host 8th Annual Focus On Healthcare Conference



    NEW YORK, July 30 /CNW/ - BMO Capital Markets, the investment and
corporate banking arm of BMO Financial Group (TSX, NYSE:   BMO), will hold its
eighth annual two-day conference, Focus On Healthcare, Tuesday, August 5 and
Wednesday, August 6, at the Millennium Broadway Hotel in New York City.
    Hosted by members of the BMO Capital Markets Healthcare Equity Research
Team including Erik Chiprich, Christine Charette, Robert Hazlett, Dave Shove,
Joanne Wuensch and Jason Zhang, this event features a unique mix of
presentations by senior executives from more than 75 leading and emerging
public and private companies focused on the following sectors:

    
    -  Biotechnology
    -  Health-care Facilities
    -  Managed Care
    -  Medical Technology & Devices
    -  Pharmacy Benefit Managers
    -  Pharmaceuticals & Specialty/Emerging Pharmaceuticals
    

    Keynote address - August 5 - Dr. Peter R. Orszag
    Dr. Orszag is the director of the Congressional Budget Office. He will
discuss themes relating to options for slowing the growth of health care
costs.

    The complete conference agenda and presentations will be available:

    http://www.bmocm.com/conferences/2008healthcare

    Media interested in attending the conference and/or scheduling an
interview should call (416) 867-3996 or toll free at 1-866-298-8385.

    
    Participating companies include(*):

    Aastrom Biosciences (ASTM)          Allos Therapeutics (ALTH)
    AEterna Zentaris (AEZS)              Archemix (private)
    Affymax (AFFY)                      ArQule (ARQL)
    AVI BioPharma (AVII)                Humana (HUM)
    Bio-Imaging Technologies (BITI)     Hythiam (HYTM)
    BioMS Medical (MS)                  Medco Health Solutions, Inc. (MHS)
    Bionovo (BNVI)                      The Parker Group (private)
    Celgene (CELG)                      Wellpoint (WLP)
    Cougar Biotechnology (CGRB)         Advanced Medical Optics (EYE)
    Emergent BioSolutions (EBS)         AtriCure (ATRC)
    Idenix Pharmaceuticals (IDIX)       BioSphere Medical, Inc. (BSMD)
    Idera Pharmaceuticals (IDRA)        C.R. Bard (BCR)
    InterMune (ITMN)                    Cardiva Medical (Private)
    Medivation (MDVN)                   Covidien (COV)
    MethylGene (MYLGF.PK)               CyroCath (CRT.TO)
    Myriad Genetics (MYGN)              ESTECH (private)
    Optimer Pharmaceuticals (OPTR)      Greatbatch (GB)
    Paratek Pharmaceuticals (private)   Integra LifeSciences (IART)
    Pharmacopeia (PCOP)                 MIV Therapeutics (MIVI.OB)
    Poniard Pharmaceuticals (PARD)      Paragon Medical (Private)
    Progenics Pharmaceuticals (PGNX)    Response Biomedical (RBM.TO)
    QLT (QLTI)                          STAAR Surgical Company (STAA)
    Reata Pharmaceuticals (private)     Stryker (SYK)
    Regeneron Pharmaceuticals (REGN)    The Cooper Companies (COO)
    Sangamo Biosciences (SGMO)          Vision-Sciences (VSCI)
    SuperGen (SUPG)                     VNUS Medical Technologies (VNUS)
    TransMolecular (private)            Antares Pharma (AIS)
    Tranzyme Pharma (private)           Clinical Data (CLDA)
    Vertex Pharmaceuticals (VRTX)       Cortex Pharmaceuticals (COR)
    Ascend Health (private)             Eli Lilly & Company (LLY)
    DSI (private)                       Enzon Pharmaceuticals, Inc. (ENZN)
    Encompass Home Health (private)     Intra-Cellular Therapies (private)
    Health Management Associates (HMA)  Ironwood Pharmaceuticals (Private)
    LCA-Vision (LCAV)                   King Pharmaceuticals (KG)
    Medical Facilities (DR_UN.TO)       MacroGenics (Private)
    Northstar Healthcare (NHC)          MDRNA (MRNA)
    NovaMed (NOVA)                      Nektar Therapeutics (NKTR)
    TLCVision (TLCV)                    Oscient Pharmaceuticals, Inc. (OSCI)
    Universal Health Services (UHS)     Penwest Pharmaceuticals (PPCO)
    US Physical Therapy (USPH)          Pozen (POZN)
    American CareSource Holdings (XSI)  Questcor Pharmaceuticals, Inc. (QSC)
    BioScrip (BIOS)                     Repligen (RGEN)
    Centene (CNC)                       Salix Pharmaceuticals (SLXP)
    Cigna (CI)                          Sepracor (SEPR)
                                        Vitae Pharmaceuticals (Private)

    (*) Agenda and participant list subject to change.
    

    About the BMO Capital Markets Healthcare Equity Research Team

    The BMO Capital Markets Healthcare Equity Research Team provides coverage
of healthcare services, medical technology, specialty and large-cap
pharmaceuticals, and biotechnology companies. The team includes: Christine
Charette (Biotechnology, Canada); Erik Chiprich (Healthcare Facilities);
Robert Hazlett (Pharmaceuticals); Dave Shove (Managed Care and Benefits);
Joanne Wuensch (Medical Technology); and Jason Zhang (Biotechnology, U.S.).

    About BMO Capital Markets

    BMO Capital Markets is a leading full-service North American financial
services provider, with 2,400 employees operating in 14 North American offices
and 26 worldwide, offering corporate, institutional and government clients
access to a complete range of investment and corporate banking products and
services. BMO Capital Markets is a member of BMO Financial Group (NYSE, TSX:
BMO), one of the largest diversified financial services providers in North
America with total assets of US $377 billion and more than 36,000 employees as
at April 30, 2008.




For further information:

For further information: Media Contacts: Orli Namian, Toronto,
orli.namian@bmo.com, (416) 867-3996; Holly Holt, New York, holly.holt@bmo.com,
(212) 885-4153; Internet: www.bmocm.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890